Tested umbilical cord stem cell exosomes for trigeminal nerve pain
Treatments studied
Part of Brain & nervous system, Mouth & dental clinical trials.
This Phase 1 study tests whether a treatment made from donated umbilical cord stem cell “exosomes” is safe for people with trigeminal neuralgia (severe facial nerve pain). It mainly focuses on safety and tolerability, and it may help by calming nerve-related pain pathways.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with trigeminal neuralgia or a peripheral (outside the brain) nerve problem
- You are willing to read and sign an informed consent form in writing
- You do not have a current active infection
- You do not have active cancer
- You are not pregnant (or, if you could become pregnant, you use reliable birth control)
- You do not have a history of organ transplant and you are not allergic to sulfur
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-stage study (Phase 1) tests whether a tiny dose given through the nose is safe for people who have had a stroke. It uses exosomes made from adult umbilical cord stem cells, mainly to look for side effects and dosing safety.
This Phase 1 study tests whether an off-the-shelf stem cell product made from donated umbilical cord tissue is safe for people with spinal cord injury. It mainly looks at side effects and safety, and may help pave the way for future effectiveness studies.
This early study tests whether two types of stem cells—made from your own fat cells versus from donated umbilical-cord cells—are safe when injected into the fluid around the spinal cord. It may help researchers find safer cell-based options for people with spinal cord injury.
This Phase 1 study tests whether an IV infusion of stem cells from donated umbilical cord tissue is safe for people with idiopathic pulmonary fibrosis. It focuses mainly on safety and tolerability, and it may help by offering a new treatment approach if the cells are safe for you.
This study tests a new treatment for skin ulcers using stem cells grown from donated umbilical cords. The cells are given to help the wound heal, and the study checks that it is safe.
This early study tests whether an IV infusion of donor-derived stem cells is safe for people with multiple sclerosis. It mainly focuses on side effects and safety, not whether it improves MS symptoms yet.
Hear when a new Peripheral Neuropathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.